CD Biosynsis focuses on both the existing and newly emerging plant chassis to help our customers harness the power of plant synthetic biology to drive a revolution in biotechnology, agriculture, biofuels, and medicine. Our scientists have many years of research experience in plant engineering and synthetic biology, and are able to help our customers overcome the technical challenges in plant chassis development.
As complex multicellular organisms, plants offer great potential for synthetic biology. Rapid advances in biotechnology allow plant synthetic biology to design and produce new traits or products by combining engineering principles with plant biology. Plant chassis has its natural advantages over microbial chassis. Plants can synthesize a variety of primary metabolites (e.g., proteins, fatty acids, and sugars) and a wide range of secondary metabolites of pharmaceutical and industrial importance by photosynthesis using only carbon dioxide and water as raw materials. Plant chassis are also free from the ethical issues that restrict the use of animal cells. Although plant synthetic biology is a rapidly evolving field, the development of an ideal plant chassis remains difficult due to the complex endogenous signaling networks in plants.
The development of plant synthetic biology is fundamentally limited by the availability of the biological parts and the modeling, construction, and tuning of synthetic gene circuits. CD Biosynsis combines plant engineering strategies with our synthetic biology toolbox to enhance our capability in developing plant chassis. Our scientists with an in-depth understanding of plant synthetic biology have been working to develop new tools and optimal strategies to help our customers fully exploit the potential of plant chassis. Our core capabilities include, but are not limited to the following:
|Synthetic Biology Toolbox||
CD Biosynsis has a team of experienced botanists who can provide valuable insights into the selection of the ideal plant chassis for our customers' intended applications. We focus on Arabidopsis, Nicotiana species, Marchantia polymorpha, Physcomitrella patens, wolffian, and tomato. We are also continuously exploring the potential for the development of those unexplored plant species as synthetic biology chassis, offering broader application possibilities.
|Plant-based bioproducts and chemicals||Plant-derived biomaterials||Biomedicine|
|Production of natural products||Pant-based biodegradable materials||Plant-derived drugs|
|Plant-derived antibodies||Plant-based filler materials||Plant-derived nutraceuticals|
|Cosmetics ingredients||Plant-based packaging materials||Plant-produced vaccines|
|Food and agriculture||Renewable bioenergy||Plant-based biosensors|
|Increasing biomass of field crops||Production of plant biomass||Environmental monitor|
|Enhancing plant resilience||Engineering of bioenergy crops||Pathogen detection|
|Improving the quality of agricultural products||Plant-based biorefinery||Monitoring gene expression|
CD Biosynsis has been continuously expanding our synthetic biology toolbox and keeping our knowledge and skills current. We provide full support for our customers' innovations in synthetic biology. If you require any further details, please feel free to contact us and let us know how we can support your new idea or project.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.